News
Alberto Jiménez Schumacher discusses cancer research advances on Aragón Radio
The ARAID researcher highlighted the potential of nanobodies for cancer diagnosis and treatment, the importance of basic research and the need for stable scientific funding.
ARAID researcher Alberto Jiménez Schumacher recently took part in an interview on Aragón Radio, where he discussed some of the current challenges and advances in cancer research. During the programme, he addressed emerging diagnostic tools, new therapeutic approaches and the essential role of fundamental research in improving patient care.
A key message of the interview was the human dimension of scientific research. Jiménez Schumacher recalled a principle shared by his mentor, researcher Carlos López-Otín, stating that "people are more important than the most important experiment". He emphasized that providing answers to families, reducing uncertainty for patients and improving diagnostic accuracy are among the most meaningful outcomes of biomedical research.
The interview also focused on the potential of camelid-derived nanobodies, which are significantly smaller than conventional antibodies. Their unique properties allow them to reach difficult biological targets, including certain brain tumours, creating new opportunities for both diagnosis and treatment.
Among their most promising applications is the concept of a virtual biopsy, which enables clinicians to obtain molecular information about a tumour through imaging techniques, reducing the need for invasive procedures. Nanobodies may also support fluorescence-guided surgery and facilitate the targeted delivery of therapeutic agents directly to tumour cells.
Jiménez Schumacher also highlighted the complexity and diversity of cancer, stressing that continued progress depends on a better understanding of the biological mechanisms underlying the disease. In this regard, he underscored the value of basic research as the foundation for future clinical advances.
Finally, he called for stable and sustained investment in science, noting that building successful research teams requires years of effort and continuity, while funding uncertainty can quickly undermine scientific progress.
Full interview available on Aragón Radio's YouTube channel: https://www.youtube.com/watch?v=p5DEd-h71tA
Share
Other news
See all